PTH-CONTAINING THERAPEUTIC/PROPHILACTIC ANTI-OSTEOPOROSIS AGENT, CHARACTERISED BY WEEKLY INTRODUCTION OF PTH IN STANDARD DOSE OF 100-200 UNITS Russian patent published in 2015 - IPC A61K33/06 A61K38/29 A61P19/08 A61P19/10 

FIELD: medicine.

SUBSTANCE: invention relates to medicine and deals with a method of treatment or prevention of osteoporosis, including introduction to a subject requiring it of a medication which contains PTH as an active ingredient, where PTH is introduced one time per week in a standard dose of 200 units, and the subject satisfies all of the following conditions: age 65 years and older, prevailing bone fractures, bone density lower than 80% of the average density of the young adult and/or a degree of bone atrophy I or higher.

EFFECT: invention ensures safety and high efficiency of the method of treating osteoporosis.

2 cl, 2 ex, 5 dwg, 35 tbl